Filing metadata

Accession number
0001209191-17-022335
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Mar 22, 2017
Reporting period
Mar 21, 2017
Description
Insider transaction

Explore SEC Filings Hub